Convertible notes and SAFEs are both instruments for raising early-stage capital without setting a company valuation—but they differ in legal structure, investor protections, and long-term cap table implications in ways that matter at scale.
Key Takeaways
- A SAFE (Simple Agreement for Future Equity) is simpler and cheaper to issue than a convertible note but offers investors fewer legal protections.
- Convertible notes carry interest and a maturity date; SAFEs do not—making SAFEs less urgent to resolve and less costly to carry.
- Both instruments convert to equity at a future priced round, typically with a discount or valuation cap providing investor upside.
- The choice between them depends less on which instrument is 'better' and more on investor preference, legal jurisdiction, and deal structure.
What They Have in Common
Both convertible notes and SAFEs are bridge financing instruments designed to allow a company to raise money quickly—typically before a formal Series A priced round—without requiring agreement on a company valuation. Both convert to equity at a future priced round, usually at a discount to the price paid by new investors or with a valuation cap that benefits early investors.
Both are standard tools in early-stage venture and angel investing. Neither represents equity until conversion occurs.
The Key Differences
| Dimension | Convertible Note | SAFE |
|---|---|---|
| Legal structure | Debt instrument with maturity date and interest | Not a debt instrument; no maturity or interest |
| Interest accrual | Yes—typically 5–8% per year | No |
| Maturity date | Yes—typically 12–24 months | No—no forced conversion deadline |
| Investor protections | More robust; debt treatment gives some priority | Simpler; less legal protection for investor |
| Cost to issue | Higher—requires legal negotiation on terms | Lower—often uses standard Y Combinator template |
| Jurisdiction compatibility | Works in most jurisdictions | Less recognized in some non-US jurisdictions |
| Typical use case | Investors who want debt-like protections or in markets where SAFEs are less common | US-based early-stage rounds with sophisticated investors familiar with the instrument |
Why the Interest Rate and Maturity Date Matter
A convertible note's maturity date creates a hard deadline: if the company hasn't raised a priced round by the time the note matures, the investor can demand repayment—or in many cases, negotiate an extension. This creates a time-pressure dynamic that can affect company decision-making, particularly if multiple notes are maturing simultaneously.
SAFEs have no such deadline. This is generally founder-friendly: there's no compulsion to raise a priced round by a specific date. But it also means investors have less leverage if the company stalls, which is why some sophisticated angel investors still prefer convertible notes in certain markets.
Valuation Caps and Discounts: The Shared Economics
Both instruments typically include a valuation cap, a discount to the next round price, or both. A valuation cap sets a ceiling on the price at which the instrument converts—meaning the investor gets equity as if the company were worth no more than the cap, even if the next round is at a higher valuation. A discount (usually 10–20%) reduces the conversion price relative to what new investors pay. These economic terms are the actual negotiating surface of both instruments, and understanding their interaction requires financial modeling rather than assumption. The National Venture Capital Association's standardized term sheet resources provide detailed frameworks for modeling these scenarios.
Which Instrument Should You Use?
The decision most often comes down to investor preference, not founder preference. Many angel investors and micro-VCs have a preferred instrument or a legal framework they're already set up to process. When an investor strongly prefers one instrument, the cost of switching is usually not worth the fight.
From a founder's perspective, SAFEs are generally simpler and cheaper to issue—especially when using the standard Y Combinator SAFE template, which has become a near-universal format in US-based early-stage investing. For rounds involving international investors or investors who specifically require debt treatment, a convertible note may be the more appropriate vehicle. These decisions connect directly to the broader investor selection process covered in What Makes a Business Idea Defensible in a Crowded Market?—the investors you choose shape the instruments you use.
What This Means for Your Cap Table
Both instruments dilute existing shareholders when they convert—but the timing and magnitude of dilution depend on the cap, discount, and the valuation at which the next priced round occurs. Founders who raise multiple rounds of convertible instruments before a priced round can face significant dilution surprises at conversion. Running the dilution scenario in a simple spreadsheet before each raise is strongly advisable.
The financial health discipline that makes capital structure decisions more rational is discussed further in How to Run a Mid-Year Strategy Reset Without Losing Momentum—strategy reviews should include a capital structure review as standard.
Where to Begin
Before your next capital raise, write down the one or two terms you care most about (cap, discount, or instrument type) and the one or two terms your likely investors care about. Find the overlap. A well-advised first conversation with an experienced startup attorney—before investor conversations begin—will save significantly more in time and legal cost than the fee for that conversation.
